Pinkie Chambers

13PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Pacific Peoples cultural determinants of healthApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|May 18, 2026
What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients' risk of hepatic and renal deterioration during chemotherapy? A qualitative study.

|Mar 08, 2026
Completion vs. early discontinuation of chemotherapy and the impact on 5-year all-cause mortality in women treated for early-stage breast cancer from 2015 to 2020: A cohort study using a target trial emulation approach.

Luke Steventon, Chengsheng Ju, Kenneth K C Man

|Feb 25, 2025
Scoping review identifying interventions that have been tested to optimise the experience of people from ethnic minority groups receiving systemic anticancer therapy (SACT).

Jurga McLean, Pinkie Chambers, Luke Steventon

|Jan 31, 2025
From prediction to practice: mitigating bias and data shift in machine-learning models for chemotherapy-induced organ dysfunction across unseen cancers.

Matthew Watson, Pinkie Chambers, Luke Steventon

|Jan 31, 2025
Association of pre-existing cardiovascular disease with administration of fluoropyrimidine chemotherapy in patients with gastrointestinal malignancies.

Aderonke Temilade Abiodun, Chengsheng Ju, Catherine A Welch

|Sep 08, 2024
The impact of inter-cycle treatment delays on overall survival in patients with advanced-stage ovarian cancer.

Luke Steventon, Kenneth K C Man, Shibani Nicum

Pageof 3

Frequent Collaborators

4 joint publications

Luke Steventon

1 joint publications

Man-Chie Chow

1 joint publications

Georgia Chisnall

1 joint publications

Nehla Djellouli